Wu X, Kushwaha N, Albert P R, Penington N J
Department of Physiology and Pharmacology, State University of New York, Health Science Center at Brooklyn, Box 29, 450 Clarkson Avenue, Brooklyn, NY 11203-2098, USA.
J Physiol. 2002 Jan 1;538(Pt 1):41-51. doi: 10.1113/jphysiol.2001.012668.
The importance of specific protein kinase C (PKC) sites for modulation of the inhibitory coupling of 5-HT(1A) receptors to N-type Ca(2+) channels was examined using patch-clamp techniques in F11 rat dorsal root ganglion x mouse neuroblastoma hybrid cells. The PKC activator phorbol 12-myristate 13-acetate (PMA, 10 nM) reduced by 28.6 +/- 6.8 % 5-HT-mediated, but not GTP-gamma-S-induced, inhibition of Ca(2+) current, whereas a higher concentration of PMA (500 nM) inhibited both the actions of 5-HT and GTP-gamma-S. 5-HT(1A) receptor expression plasmids with or without mutation of a single PKC site in the second intracellular loop (i2, T149A) or of three PKC sites located in the third intracellular loop (i3, T229A-S253G-T343A) were stably transfected into F11 cells. The T149A 5 HT(1A) receptor inhibited forskolin-stimulated cyclic AMP levels but was largely uncoupled from Ca(2+) channel modulation. In one (i2) clone a response rate to 5-HT of 31.6 % was obtained. The T149A mutant displayed markedly reduced sensitivity to PMA (10 nM) compared to wild-type 5-HT(1A) receptors, with only a 13.4 +/- 3 % reduction in 5-HT-induced channel inhibition; when exposed to 500 nM PMA, reductions in the action of 5-HT were comparable to those of the wild-type receptor. By contrast, the i3 mutant displayed comparable sensitivity to the wild-type 5-HT(1A) receptor to either concentration of PMA. PMA at 10 nM exhibited a similar uncoupling effect on the response of the endogenous opiate receptor to the agonist D-alanine-5-leucine-enkephalin (DADLE) in wild-type and T149A mutant-expressing clones. The T149 site of the 5-HT(1A) receptor is crucial for receptor uncoupling by sub-maximal PKC activation while at maximal PKC activation, downstream sites uncouple G proteins from the N-type Ca(2+) channel.
运用膜片钳技术,在F11大鼠背根神经节x小鼠神经母细胞瘤杂交细胞中,研究了特定蛋白激酶C(PKC)位点对5-羟色胺(5-HT)1A受体与N型钙通道抑制性偶联调节的重要性。PKC激活剂佛波醇12-肉豆蔻酸酯13-乙酸酯(PMA,10 nM)使5-HT介导的而非GTP-γ-S诱导的钙电流抑制降低了28.6±6.8%,而更高浓度的PMA(500 nM)则同时抑制了5-HT和GTP-γ-S的作用。将具有或不具有第二细胞内环(i2,T149A)中单个PKC位点或位于第三细胞内环(i3,T229A-S253G-T343A)中三个PKC位点突变的5-HT1A受体表达质粒稳定转染到F11细胞中。T149A 5-HT1A受体抑制了福司可林刺激的环磷酸腺苷(cAMP)水平,但在很大程度上与钙通道调节解偶联。在一个(i2)克隆中,对5-HT的反应率为31.6%。与野生型5-HT1A受体相比,T149A突变体对PMA(10 nM)的敏感性显著降低,5-HT诱导的通道抑制仅降低了13.4±3%;当暴露于500 nM PMA时,5-HT作用的降低与野生型受体相当。相比之下,i3突变体对两种浓度PMA的敏感性与野生型5-HT1A受体相当。在表达野生型和T149A突变体的克隆中,10 nM的PMA对内源性阿片受体对激动剂D-丙氨酸-5-亮氨酸-脑啡肽(DADLE)的反应表现出类似的解偶联作用。5-HT1A受体的T149位点对于亚最大PKC激活导致的受体解偶联至关重要,而在最大PKC激活时,下游位点使G蛋白与N型钙通道解偶联。